Preoperative C-Reactive Protein Predicts Mid-Term Outcome After Cardiac Surgery

Annals of Thoracic Surgery

Volumn 82, Issue 6, 2006, Pages 2170-2178

  Cappabianca, Giangiuseppe ^a   Paparella, Domenico ^a   Visicchio, Giuseppe ^a   Capone, Giuseppe ^a   Lionetti, Giosuè ^a   Numis, Flora ^a   Ferrara, Pietro ^a   D'Agostino, Chiara ^a   de Luca Tupputi Schinosa, Luigi ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART SURGERY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; WOUND INFECTION;

AGED; C-REACTIVE PROTEIN; CARDIAC SURGICAL PROCEDURES; FEMALE; HOSPITALIZATION; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33751189161     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.06.039     Document Type: Article

References (30)

1. Koenig W., Sund M., Fröhlich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99 (1999) 237-242
2. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular event. N Engl J Med 347 (2002) 1557-1565
3. Ridker P.M., and Cook N.R. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 109 (2004) 1955-1959
4. Danesh J., Wheeler J.G., Hirshfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
5. Zebrack J.S., Anderson J.L., Maycock C.A., Horne B.D., Bair T.L., and Muhlestein J.B. Usefulness of high sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 89 (2002) 145-149
6. Bickel C., Rupprecht H.J., Blankenberg S., et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89 (2002) 901-908
7. Dibra A., Mehilli J., Braun S., et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722
8. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schächinger V., and Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
9. Walter D.H., Fichtlscherer S., Britten M.B., et al. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 38 (2001) 2006-2012
10. Galante A., Pietroiusti A., Vellini M., et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 38 (2001) 1078-1082
11. Gerber I.L., Stewart R.A., Hammett C.J., et al. Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 92 (2003) 1129-1132
12. Otto C.M., Kuusisto J., Reichenback D.D., Gown A.M., and O'Brien K.D. Characterization of the early lesion of "degenerative" valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90 (1994) 844-853
13. Gölbasi Z., Uçar Ö., and Keles T. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 4 (2002) 593-595
14. Krasuski R.A., Bush A., Kay J.E., et al. C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. Am Heart J 146 (2003) 1099-1104
15. Samsonov M., Lopatin J., and Tiltz G.P. The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure. J Intern Med 243 (1998) 93-98
16. Alonso-Martinez J.L., Llorente-Diez B., Echegaray-Angara M., Olaz-Preciado F., Urbieta-Echezarreta M., and Gonzalez-Arencibia C. C-reactive protein as predictor of improvement and readmission in heart failure. Eur J Heart Fail 4 (2002) 331-336
17. Biancari F., Lahtinen, Lepojarvi S., et al. Preoperative C-reactive protein and outcome after coronary artery bypass. Ann Thorac Surg 76 (2003) 2007-2012
18. Boeken U., Feindt P., Zimmermann N., Kalweiy G., Petzold T., and Gams E. Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. Eur J Cardiothorac Surg 13 (1998) 541-545
19. Fransen E.J., Maessen J.G., Elenbaas T.W., van Aarnhem E.E., and Dieijen-Visser M.P. Increased preoperative C-reactive protein plasma levels as risk factor for post-operative infections. Ann Thorac Surg 67 (1999) 134-138
20. Gaudino M., Nasso G., Andreotti F., et al. Preoperative C-reactive protein level and outcome following cardiac surgery. Eur J Cardiothorac Surg 22 (2002) 521-526
21. Fowler V.G., O'Brien S., Muhlbaier L.W., Corey G.R., Ferguson T.B., and Peterson E.D. Clinical predictors of major infections after cardiac surgery. Circulation 112 9 suppl (2005) I358-I365
22. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
23. Yamashita H., Shimada K., Seki E., Mokuno H., and Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 91 (2003) 133-136
24. Meduri G.U., Kanagat S., Stefan J., Tolley E., and Schaberg S. Cytokines IL-1beta, IL-6 and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med 160 (1999) 961-967
25. Meduri G.U. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Crit Care 6 (2002) 24-29
26. Szmitko P.E., Wang C.H., Weisel R.D., de Almeida J.R., Anderson T.J., and Verma S. New markers of inflammation and endothelial cell activation: part I. Circulation 108 (2003) 1917-1923
27. Verma S., Badiwala M.V., Weisel R.D., et al. C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg 126 (2003) 1886-1891
28. Devaraj S., Xu D.Y., and Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 107 (2003) 398-404
29. Moor E., Blomback M., Silveira A., et al. Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure. Thromb Res 98 (2000) 39-49
30. Clark L.L., Ikonomidis J.S., Crawford Jr. F.A., et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg 131 (2006) 679-685